OREX
Orexigen Therapeutics, Inc.
OREX
OREX
Delisted
OREX was delisted on the 3rd of April, 2018.
129 hedge funds and large institutions have $605M invested in Orexigen Therapeutics, Inc. in 2014 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 57 increasing their positions, 32 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
4% more funds holding
Funds holding: 124 → 129 (+5)
Holders
129
Holding in Top 10
1
Calls
$12.2M
Puts
$10.2M
Top Buyers
| 1 | +$24.9M | |
| 2 | +$16.8M | |
| 3 | +$11.1M | |
| 4 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$10.8M |
| 5 |
FCMI
Foresite Capital Management I
Larkspur,
California
|
+$8.13M |
Top Sellers
| 1 | -$21.6M | |
| 2 | -$12.6M | |
| 3 | -$5.63M | |
| 4 |
D.E. Shaw & Co
New York
|
-$5.38M |
| 5 |
First Manhattan
New York
|
-$4.89M |